Tuesday, October 12, 2010
Pfizer gibed on Tues to bribe King Pharmaceuticals, a shaper of hurting medicinal drugs, for $3.6 billion in immediate payment, in the drug shaper's first major mess since its megahit purchase of Wyeth last class. Under the terms of the understanding, Pfizer will start a tender offer in which it will pay $14.25 a percentage in immediate payment, a 40 pct premium to King's Mon shutting stock Leontyne Price.
Through the lot, Pfizer requires to increase its photograph to the botheration medicament marketplace, a line that is anticipated to grow as the population years. King focuses on creating hurting drugs that have mechanisms designed to keep misuse. Beyond hurting drugs like like Skelaxin and Embeda, King besides creates the EpiPen pinch drug injector and various veterinary drugs.
From: http://ping.fm/KTbns
Through the lot, Pfizer requires to increase its photograph to the botheration medicament marketplace, a line that is anticipated to grow as the population years. King focuses on creating hurting drugs that have mechanisms designed to keep misuse. Beyond hurting drugs like like Skelaxin and Embeda, King besides creates the EpiPen pinch drug injector and various veterinary drugs.
From: http://ping.fm/KTbns